| Year |
Citation |
Score |
| 2023 |
Li B, Zhang T, Cao H, Ferro V, Li J, Yu M. Identification of a Pentasaccharide Lead Compound with High Affinity to the SARS-CoV-2 Spike Protein via In Silico Screening. International Journal of Molecular Sciences. 24. PMID 38003304 DOI: 10.3390/ijms242216115 |
0.363 |
|
| 2023 |
Mutch AL, Ferro V, A A, Grøndahl L. Synthesis of sulfated alginate from its tributylammonium salt: Comparing the sulfating agents HSO-DCC and SO·py. Carbohydrate Polymers. 324: 121488. PMID 37985083 DOI: 10.1016/j.carbpol.2023.121488 |
0.317 |
|
| 2023 |
Rayner B, Verderosa AD, Ferro V, Blaskovich MAT. Siderophore conjugates to combat antibiotic-resistant bacteria. Rsc Medicinal Chemistry. 14: 800-822. PMID 37252105 DOI: 10.1039/d2md00465h |
0.271 |
|
| 2023 |
Hammond E, Ferro V. An Enzymatic Activity Assay for Heparanase That Is Useful for Evaluating Clinically Relevant Inhibitors and Studying Kinetics. Methods in Molecular Biology (Clifton, N.J.). 2619: 227-238. PMID 36662473 DOI: 10.1007/978-1-0716-2946-8_16 |
0.338 |
|
| 2022 |
Doherty GG, Ler GJM, Wimmer N, Bernhardt PV, Ashmus RA, Vocadlo DJ, Armstrong ZWB, Davies GJ, Maccarana M, Li JP, Kayal Y, Ferro V. Synthesis of Uronic Acid 1-Azasugars as Putative Inhibitors of α-Iduronidase, β-Glucuronidase and Heparanase. Chembiochem : a European Journal of Chemical Biology. PMID 36453606 DOI: 10.1002/cbic.202200619 |
0.734 |
|
| 2022 |
See NW, Xu X, Ferro V. An Improved Protocol for the Stereoselective Synthesis of β-d-Glycosyl Fluorides from 2--Acyl Thioglycosides. The Journal of Organic Chemistry. 87: 14230-14240. PMID 36222442 DOI: 10.1021/acs.joc.2c01748 |
0.736 |
|
| 2022 |
Parafioriti M, Ni M, Petitou M, Mycroft-West CJ, Rudd TR, Gandhi NS, Ferro V, Turnbull JE, Lima MA, Skidmore MA, Fernig DG, Yates EA, Bisio A, Guerrini M, Elli S. Evidence for multiple binding modes in the initial contact between SARS-CoV-2 spike S1 protein and cell surface glycans. Chemistry (Weinheim An Der Bergstrasse, Germany). PMID 36134621 DOI: 10.1002/chem.202202599 |
0.336 |
|
| 2022 |
Lo MW, Amarilla AA, Lee JD, Albornoz EA, Modhiran N, Clark RJ, Ferro V, Chhabra M, Khromykh AA, Watterson D, Woodruff TM. SARS-CoV-2 triggers complement activation through interactions with heparan sulfate. Clinical & Translational Immunology. 11: e1413. PMID 35999893 DOI: 10.1002/cti2.1413 |
0.726 |
|
| 2022 |
Guimond SE, Mycroft-West CJ, Gandhi NS, Tree JA, Le TT, Spalluto CM, Humbert MV, Buttigieg KR, Coombes N, Elmore MJ, Wand M, Nyström K, Said J, Setoh YX, Amarilla AA, ... ... Ferro V, et al. Synthetic Heparan Sulfate Mimetic Pixatimod (PG545) Potently Inhibits SARS-CoV-2 by Disrupting the Spike-ACE2 Interaction. Acs Central Science. 8: 527-545. PMID 35647275 DOI: 10.1021/acscentsci.1c01293 |
0.745 |
|
| 2022 |
Gockel LM, Nekipelov K, Ferro V, Bendas G, Schlesinger M. Tumour cell-activated platelets modulate the immunological activity of CD4, CD8, and NK cells, which is efficiently antagonized by heparin. Cancer Immunology, Immunotherapy : Cii. 71: 2523-2533. PMID 35285006 DOI: 10.1007/s00262-022-03186-5 |
0.295 |
|
| 2022 |
Chhabra M, Wilson JC, Wu L, Davies GJ, Gandhi NS, Ferro V. Structural insights into pixatimod (PG545) inhibition of heparanase, a key enzyme in cancer and viral infections. Chemistry (Weinheim An Der Bergstrasse, Germany). PMID 34981584 DOI: 10.1002/chem.202104222 |
0.757 |
|
| 2021 |
Chhabra M, Wimmer N, He QQ, Ferro V. Development of Improved Synthetic Routes to Pixatimod (PG545), a Sulfated Oligosaccharide-Steroid Conjugate. Bioconjugate Chemistry. PMID 34652896 DOI: 10.1021/acs.bioconjchem.1c00453 |
0.781 |
|
| 2021 |
Chhabra M, Doherty GG, See NW, Gandhi NS, Ferro V. From Cancer to COVID-19: A Perspective on Targeting Heparan Sulfate-Protein Interactions. Chemical Record (New York, N.Y.). PMID 34145723 DOI: 10.1002/tcr.202100125 |
0.664 |
|
| 2021 |
Schuurs ZP, Hammond E, Elli S, Rudd TR, Mycroft-West CJ, Lima MA, Skidmore MA, Karlsson R, Chen YH, Bagdonaite I, Yang Z, Ahmed YA, Richard DJ, Turnbul J, Ferro V, et al. Evidence of a Putative Glycosaminoglycan Binding Site on the Glycosylated SARS-CoV-2 Spike Protein N-terminal domain. Computational and Structural Biotechnology Journal. PMID 33968333 DOI: 10.1016/j.csbj.2021.05.002 |
0.3 |
|
| 2021 |
Huang X, Reye G, Momot KI, Blick T, Lloyd T, Tilley WD, Hickey TE, Snell CE, Okolicsanyi RK, Haupt LM, Ferro V, Thompson EW, Hugo HJ. Corrigendum: Heparanase Promotes Syndecan-1 Expression to Mediate Fibrillar Collagen and Mammographic Density in Human Breast Tissue Cultured . Frontiers in Cell and Developmental Biology. 9: 678589. PMID 33869234 DOI: 10.3389/fcell.2021.678589 |
0.212 |
|
| 2021 |
Gockel LM, Heyes M, Li H, Al Nahain A, Gorzelanny C, Schlesinger M, Holdenrieder S, Li JP, Ferro V, Bendas G. Inhibition of Tumor-Host Cell Interactions Using Synthetic Heparin Mimetics. Acs Applied Materials & Interfaces. 13: 7080-7093. PMID 33533245 DOI: 10.1021/acsami.0c20744 |
0.419 |
|
| 2020 |
Mycroft-West CJ, Su D, Pagani I, Rudd TR, Elli S, Gandhi NS, Guimond SE, Miller GJ, Meneghetti MCZ, Nader HB, Li Y, Nunes QM, Procter P, Mancini N, Clementi M, ... ... Ferro V, et al. Heparin Inhibits Cellular Invasion by SARS-CoV-2: Structural Dependence of the Interaction of the Spike S1 Receptor-Binding Domain with Heparin. Thrombosis and Haemostasis. 120: 1700-1715. PMID 33368089 DOI: 10.1055/s-0040-1721319 |
0.37 |
|
| 2020 |
Boittier ED, Burns JM, Gandhi NS, Ferro V. GlycoTorch Vina: Docking Designed and Tested for Glycosaminoglycans. Journal of Chemical Information and Modeling. PMID 33152249 DOI: 10.1021/acs.jcim.0c00373 |
0.204 |
|
| 2020 |
Wu L, Wimmer N, Davies GJ, Ferro V. Structural insights into heparanase activity using a fluorogenic heparan sulfate disaccharide. Chemical Communications (Cambridge, England). PMID 33073275 DOI: 10.1039/d0cc05932c |
0.33 |
|
| 2020 |
Mohamed S, He QQ, Singh AA, Ferro V. Mucopolysaccharidosis type II (Hunter syndrome): Clinical and biochemical aspects of the disease and approaches to its diagnosis and treatment. Advances in Carbohydrate Chemistry and Biochemistry. 77: 71-117. PMID 33004112 DOI: 10.1016/bs.accb.2019.09.001 |
0.756 |
|
| 2020 |
Huang X, Reye G, Momot KI, Blick T, Lloyd T, Tilley WD, Hickey TE, Snell CE, Okolicsanyi RK, Haupt LM, Ferro V, Thompson EW, Hugo HJ. Heparanase Promotes Syndecan-1 Expression to Mediate Fibrillar Collagen and Mammographic Density in Human Breast Tissue Cultured . Frontiers in Cell and Developmental Biology. 8: 599. PMID 32760722 DOI: 10.3389/fcell.2020.00599 |
0.308 |
|
| 2020 |
Nahain AA, Ignjatovic V, Monagle P, Tsanaktsidis J, Vamvounis G, Ferro V. Sulfonated RAFT Copolymers as Heparin Mimetics: Synthesis, Reactivity Ratios, and Anticoagulant Activity. Macromolecular Bioscience. e2000110. PMID 32627962 DOI: 10.1002/mabi.202000110 |
0.752 |
|
| 2020 |
Chhabra M, Ferro V. PI-88 and Related Heparan Sulfate Mimetics. Advances in Experimental Medicine and Biology. 1221: 473-491. PMID 32274723 DOI: 10.1007/978-3-030-34521-1_19 |
0.73 |
|
| 2019 |
Nahain AA, Ignjatovic V, Monagle P, Tsanaktsidis J, Vamvounis G, Ferro V. Anticoagulant Heparin Mimetics via RAFT Polymerization. Biomacromolecules. 21: 1009-1021. PMID 31841320 DOI: 10.1021/acs.biomac.9b01688 |
0.746 |
|
| 2019 |
He QQ, Trim PJ, Lau AA, King BM, Hopwood JJ, Hemsley KM, Snel MF, Ferro V. Synthetic disaccharide standards enable quantitative analysis of stored heparan sulfate in MPS IIIA murine brain regions. Acs Chemical Neuroscience. PMID 31264853 DOI: 10.1021/acschemneuro.9b00328 |
0.479 |
|
| 2019 |
Supramaniam A, Bielefeldt-Ohmann H, Rudd PA, Webster J, Ferro V, Herrero LJ. PG545 treatment reduces RRV-induced elevations of AST, ALT with secondary lymphoid organ alterations in C57BL/6 mice. Plos One. 14: e0217998. PMID 31170255 DOI: 10.1371/journal.pone.0217998 |
0.23 |
|
| 2019 |
Modhiran N, Gandhi NS, Wimmer N, Cheung S, Stacey K, Young PR, Ferro V, Watterson D. Dual targeting of dengue virus virions and NS1 protein with the heparan sulfate mimic PG545. Antiviral Research. PMID 31085206 DOI: 10.1016/J.Antiviral.2019.05.004 |
0.34 |
|
| 2019 |
Islam N, Wang H, Maqbool F, Ferro V. In Vitro Enzymatic Digestibility of Glutaraldehyde-Crosslinked Chitosan Nanoparticles in Lysozyme Solution and Their Applicability in Pulmonary Drug Delivery. Molecules (Basel, Switzerland). 24. PMID 30939857 DOI: 10.3390/molecules24071271 |
0.233 |
|
| 2019 |
Boittier ED, Gandhi NS, Ferro V, Coombe DR. Cross-Species Analysis of Glycosaminoglycan Binding Proteins Reveals Some Animal Models Are "More Equal" than Others. Molecules (Basel, Switzerland). 24. PMID 30845788 DOI: 10.3390/molecules24050924 |
0.328 |
|
| 2018 |
Chhabra M, Ferro V. The Development of Assays for Heparanase Enzymatic Activity: Towards a Gold Standard. Molecules (Basel, Switzerland). 23. PMID 30441818 DOI: 10.3390/molecules23112971 |
0.75 |
|
| 2018 |
He QQ, Trim PJ, Snel MF, Hopwood JJ, Ferro V. Synthesis and mass spectrometric analysis of disaccharides from methanolysis of heparan sulfate. Organic & Biomolecular Chemistry. PMID 30403218 DOI: 10.1039/c8ob02225a |
0.489 |
|
| 2018 |
Mu Y, Schulz BL, Ferro V. Applications of Ion Mobility-Mass Spectrometry in Carbohydrate Chemistry and Glycobiology. Molecules (Basel, Switzerland). 23. PMID 30301275 DOI: 10.3390/molecules23102557 |
0.256 |
|
| 2018 |
Elli S, Stancanelli E, Handley PN, Carroll A, Urso E, Guerrini M, Ferro V. Structural and Conformational Studies of the Heparan Sulfate Mimetic PI-88. Glycobiology. PMID 30053088 DOI: 10.1093/glycob/cwy068 |
0.352 |
|
| 2018 |
Nahain AA, Ignjatovic V, Monagle P, Tsanaktsidis J, Ferro V. Heparin mimetics with anticoagulant activity. Medicinal Research Reviews. 38: 1582-1613. PMID 29446104 DOI: 10.1002/med.21489 |
0.748 |
|
| 2018 |
Supramaniam A, Lui X, Ferro V, Herrero L. Prophylactic anti-heparanase activity by PG545 is anti-viraland protects against Ross River virus disease in mice. Antimicrobial Agents and Chemotherapy. PMID 29437628 DOI: 10.1128/AAC.01959-17 |
0.284 |
|
| 2017 |
Handley PN, Carroll A, Ferro V. New structural insights into the oligosaccharide phosphate fraction of Pichia (Hansenula) holstii NRRL Y2448 phosphomannan. Carbohydrate Research. 446: 68-75. PMID 28531457 DOI: 10.1016/j.carres.2017.05.008 |
0.33 |
|
| 2016 |
Ferro V. Glycosaminoglycans and Their Mimetics. Molecules (Basel, Switzerland). 22. PMID 28029141 DOI: 10.3390/molecules22010020 |
0.181 |
|
| 2016 |
Islam N, Ferro V. Recent advances in chitosan-based nanoparticulate pulmonary drug delivery. Nanoscale. PMID 27439116 DOI: 10.1039/c6nr03256g |
0.257 |
|
| 2016 |
Muhsin MD, George G, Beagley K, Ferro V, Wang H, Islam N. Effects of chemical conjugation of L-leucine to chitosan on dispersibility and controlled release of drug from a nanoparticulate dry powder inhaler formulation. Molecular Pharmaceutics. PMID 26998555 DOI: 10.1021/acs.molpharmaceut.5b00859 |
0.254 |
|
| 2016 |
Mohamed S, Krenske EH, Ferro V. The stereoselectivities of tributyltin hydride-mediated reductions of 5-bromo-d-glucuronides to l-iduronides are dependent on the anomeric substituent: syntheses and DFT calculations. Organic & Biomolecular Chemistry. PMID 26878700 DOI: 10.1039/C6Ob00283H |
0.759 |
|
| 2016 |
Konara CS, Barnard RT, Hine D, Siegel E, Ferro V. The Tortoise and the Hare: Evolving Regulatory Landscapes for Biosimilars. Trends in Biotechnology. 34: 70-83. PMID 26620970 DOI: 10.1016/j.tibtech.2015.10.009 |
0.256 |
|
| 2015 |
Mohamed S, Ferro V. Synthetic Approaches to L-Iduronic Acid and L-Idose: Key Building Blocks for the Preparation of Glycosaminoglycan Oligosaccharides. Advances in Carbohydrate Chemistry and Biochemistry. 72: 21-61. PMID 26613814 DOI: 10.1016/bs.accb.2015.07.001 |
0.774 |
|
| 2015 |
Shawky MS, Ricciardelli C, Lord M, Whitelock J, Ferro V, Britt K, Thompson EW. Proteoglycans: Potential Agents in Mammographic Density and the Associated Breast Cancer Risk. Journal of Mammary Gland Biology and Neoplasia. 20: 121-31. PMID 26501889 DOI: 10.1007/s10911-015-9346-z |
0.26 |
|
| 2014 |
Muhsin MD, George G, Beagley K, Ferro V, Armitage C, Islam N. Synthesis and toxicological evaluation of a chitosan-L-leucine conjugate for pulmonary drug delivery applications. Biomacromolecules. 15: 3596-607. PMID 25191851 DOI: 10.1021/bm5008635 |
0.277 |
|
| 2014 |
Wilson JC, Laloo AE, Singh S, Ferro V. 1H NMR spectroscopic studies establish that heparanase is a retaining glycosidase. Biochemical and Biophysical Research Communications. 443: 185-8. PMID 24291708 DOI: 10.1016/j.bbrc.2013.11.079 |
0.342 |
|
| 2013 |
Ferro V. Heparan sulfate inhibitors and their therapeutic implications in inflammatory illnesses. Expert Opinion On Therapeutic Targets. 17: 965-75. PMID 23789629 DOI: 10.1517/14728222.2013.811491 |
0.342 |
|
| 2013 |
Plummer PN, Freeman R, Taft RJ, Vider J, Sax M, Umer BA, Gao D, Johns C, Mattick JS, Wilton SD, Ferro V, McMillan NA, Swarbrick A, Mittal V, Mellick AS. MicroRNAs regulate tumor angiogenesis modulated by endothelial progenitor cells. Cancer Research. 73: 341-52. PMID 22836757 DOI: 10.1158/0008-5472.Can-12-0271 |
0.213 |
|
| 2012 |
Liu L, Li C, Cochran S, Feder D, Guddat LW, Ferro V. A focused sulfated glycoconjugate Ugi library for probing heparan sulfate-binding angiogenic growth factors. Bioorganic & Medicinal Chemistry Letters. 22: 6190-4. PMID 22929233 DOI: 10.1016/j.bmcl.2012.08.001 |
0.259 |
|
| 2012 |
Fairweather JK, Liu L, Karoli T, Ferro V. Synthesis of disaccharides containing 6-deoxy-α-L-talose as potential heparan sulfate mimetics. Molecules (Basel, Switzerland). 17: 9790-802. PMID 22895025 DOI: 10.3390/molecules17089790 |
0.36 |
|
| 2012 |
Liu L, Li C, Cochran S, Jimmink S, Ferro V. Synthesis of a heparan sulfate mimetic library targeting FGF and VEGF via click chemistry on a monosaccharide template. Chemmedchem. 7: 1267-75. PMID 22615183 DOI: 10.1002/cmdc.201200151 |
0.288 |
|
| 2012 |
Ferro V, Liu L, Johnstone KD, Wimmer N, Karoli T, Handley P, Rowley J, Dredge K, Li CP, Hammond E, Davis K, Sarimaa L, Harenberg J, Bytheway I. Discovery of PG545: a highly potent and simultaneous inhibitor of angiogenesis, tumor growth, and metastasis. Journal of Medicinal Chemistry. 55: 3804-13. PMID 22458531 DOI: 10.1021/jm201708h |
0.383 |
|
| 2012 |
Lundin A, Bergström T, Andrighetti-Fröhner CR, Bendrioua L, Ferro V, Trybala E. Potent anti-respiratory syncytial virus activity of a cholestanol-sulfated tetrasaccharide conjugate. Antiviral Research. 93: 101-9. PMID 22101246 DOI: 10.1016/J.Antiviral.2011.11.002 |
0.32 |
|
| 2011 |
Pearson AG, Kiefel MJ, Ferro V, von Itzstein M. Synthesis of simple heparanase substrates. Organic & Biomolecular Chemistry. 9: 4614-25. PMID 21505696 DOI: 10.1039/c1ob05165b |
0.357 |
|
| 2010 |
Said J, Trybala E, Andersson E, Johnstone K, Liu L, Wimmer N, Ferro V, Bergström T. Lipophile-conjugated sulfated oligosaccharides as novel microbicides against HIV-1. Antiviral Research. 86: 286-95. PMID 20307578 DOI: 10.1016/J.Antiviral.2010.03.011 |
0.292 |
|
| 2010 |
Ekblad M, Adamiak B, Bergstrom T, Johnstone KD, Karoli T, Liu L, Ferro V, Trybala E. A highly lipophilic sulfated tetrasaccharide glycoside related to muparfostat (PI-88) exhibits virucidal activity against herpes simplex virus. Antiviral Research. 86: 196-203. PMID 20176055 DOI: 10.1016/J.Antiviral.2010.02.318 |
0.317 |
|
| 2010 |
Johnstone KD, Karoli T, Liu L, Dredge K, Copeman E, Li CP, Davis K, Hammond E, Bytheway I, Kostewicz E, Chiu FC, Shackleford DM, Charman SA, Charman WN, Harenberg J, ... ... Ferro V, et al. Synthesis and biological evaluation of polysulfated oligosaccharide glycosides as inhibitors of angiogenesis and tumor growth. Journal of Medicinal Chemistry. 53: 1686-99. PMID 20128596 DOI: 10.1021/jm901449m |
0.34 |
|
| 2010 |
Hammond E, Li CP, Ferro V. Development of a colorimetric assay for heparanase activity suitable for kinetic analysis and inhibitor screening. Analytical Biochemistry. 396: 112-6. PMID 19748475 DOI: 10.1016/j.ab.2009.09.007 |
0.288 |
|
| 2009 |
Fairweather JK, Karoli T, Liu L, Bytheway I, Ferro V. Synthesis of a heparan sulfate mimetic disaccharide with a conformationally locked residue from a common intermediate. Carbohydrate Research. 344: 2394-8. PMID 19819428 DOI: 10.1016/j.carres.2009.09.012 |
0.318 |
|
| 2009 |
Cochran S, Li CP, Ferro V. A surface plasmon resonance-based solution affinity assay for heparan sulfate-binding proteins. Glycoconjugate Journal. 26: 577-87. PMID 19034645 DOI: 10.1007/s10719-008-9210-0 |
0.267 |
|
| 2008 |
Liu L, Bytheway I, Karoli T, Fairweather JK, Cochran S, Li C, Ferro V. Design, synthesis, FGF-1 binding, and molecular modeling studies of conformationally flexible heparin mimetic disaccharides. Bioorganic & Medicinal Chemistry Letters. 18: 344-9. PMID 17981035 DOI: 10.1016/j.bmcl.2007.10.071 |
0.307 |
|
| 2008 |
Fairweather JK, Hammond E, Johnstone KD, Ferro V. Synthesis and heparanase inhibitory activity of sulfated mannooligosaccharides related to the antiangiogenic agent PI-88. Bioorganic & Medicinal Chemistry. 16: 699-709. PMID 17967543 DOI: 10.1016/j.bmc.2007.10.044 |
0.4 |
|
| 2007 |
Adamiak B, Ekblad M, Bergström T, Ferro V, Trybala E. Herpes simplex virus type 2 glycoprotein G is targeted by the sulfated oligo- and polysaccharide inhibitors of virus attachment to cells. Journal of Virology. 81: 13424-34. PMID 17928351 DOI: 10.1128/Jvi.01528-07 |
0.286 |
|
| 2007 |
Zammit SC, Ferro V, Hammond E, Rizzacasa MA. Enantiospecific synthesis of the heparanase inhibitor (+)-trachyspic acid and stereoisomers from a common precursor. Organic & Biomolecular Chemistry. 5: 2826-34. PMID 17700851 DOI: 10.1039/b708594j |
0.363 |
|
| 2007 |
Ferro V, Dredge K, Liu L, Hammond E, Bytheway I, Li C, Johnstone K, Karoli T, Davis K, Copeman E, Gautam A. PI-88 and novel heparan sulfate mimetics inhibit angiogenesis. Seminars in Thrombosis and Hemostasis. 33: 557-68. PMID 17629854 DOI: 10.1055/s-2007-982088 |
0.341 |
|
| 2007 |
Ekblad M, Adamiak B, Bergefall K, Nenonen H, Roth A, Bergstrom T, Ferro V, Trybala E. Molecular basis for resistance of herpes simplex virus type 1 mutants to the sulfated oligosaccharide inhibitor PI-88. Virology. 367: 244-252. PMID 17604805 DOI: 10.1016/J.Virol.2007.05.040 |
0.271 |
|
| 2006 |
Ekblad M, Bergström T, Banwell MG, Bonnet M, Renner J, Ferro V, Trybala E. Anti-herpes simplex virus activities of two novel disulphated cyclitols. Antiviral Chemistry & Chemotherapy. 17: 97-106. PMID 17042331 DOI: 10.1177/095632020601700205 |
0.311 |
|
| 2006 |
Adams Y, Freeman C, Schwartz-Albiez R, Ferro V, Parish CR, Andrews KT. Inhibition of Plasmodium falciparum growth in vitro and adhesion to chondroitin-4-sulfate by the heparan sulfate mimetic PI-88 and other sulfated oligosaccharides Antimicrobial Agents and Chemotherapy. 50: 2850-2852. PMID 16870784 DOI: 10.1128/AAC.00313-06 |
0.308 |
|
| 2005 |
Karoli T, Liu L, Fairweather JK, Hammond E, Li CP, Cochran S, Bergefall K, Trybala E, Addison RS, Ferro V. Synthesis, biological activity, and preliminary pharmacokinetic evaluation of analogues of a phosphosulfomannan angiogenesis inhibitor (PI-88). Journal of Medicinal Chemistry. 48: 8229-36. PMID 16366604 DOI: 10.1021/jm050618p |
0.344 |
|
| 2005 |
Pearson AG, Kiefel MJ, Ferro V, von Itzstein M. Towards the synthesis of aryl glucuronides as potential heparanase probes. An interesting outcome in the glycosidation of glucuronic acid with 4-hydroxycinnamic acid. Carbohydrate Research. 340: 2077-85. PMID 16054610 DOI: 10.1016/j.carres.2005.06.029 |
0.304 |
|
| 2005 |
Freeman C, Liu L, Banwell MG, Brown KJ, Bezos A, Ferro V, Parish CR. Use of sulfated linked cyclitols as heparan sulfate mimetics to probe the heparin/heparan sulfate binding specificity of proteins. The Journal of Biological Chemistry. 280: 8842-9. PMID 15632177 DOI: 10.1074/Jbc.M410769200 |
0.385 |
|
| 2005 |
Fairweather JK, Karoli T, Ferro V. The synthesis of phosphorylated disaccharide components of the extracellular phosphomannan of Pichia (Hansenula) holstii NRRL Y-2448. Bioorganic & Medicinal Chemistry. 12: 6063-75. PMID 15519152 DOI: 10.1016/j.bmc.2004.09.005 |
0.283 |
|
| 2004 |
Levidiotis V, Freeman C, Punler M, Martinello P, Creese B, Ferro V, van der Vlag J, Berden JH, Parish CR, Power DA. A synthetic heparanase inhibitor reduces proteinuria in passive Heymann nephritis. Journal of the American Society of Nephrology : Jasn. 15: 2882-92. PMID 15504941 DOI: 10.1097/01.ASN.0000142426.55612.6D |
0.292 |
|
| 2004 |
Ferro V, Hammond E, Fairweather JK. The development of inhibitors of heparanase, a key enzyme involved in tumour metastasis, angiogenesis and inflammation. Mini Reviews in Medicinal Chemistry. 4: 693-702. PMID 15279603 |
0.285 |
|
| 2004 |
Nyberg K, Ekblad M, Bergström T, Freeman C, Parish CR, Ferro V, Trybala E. The low molecular weight heparan sulfate-mimetic, PI-88, inhibits cell-to-cell spread of herpes simplex virus. Antiviral Research. 63: 15-24. PMID 15196816 DOI: 10.1016/J.Antiviral.2004.01.001 |
0.296 |
|
| 2004 |
Liu L, Ping Li C, Cochran S, Ferro V. Application of the four-component Ugi condensation for the preparation of sulfated glycoconjugate libraries. Bioorganic & Medicinal Chemistry Letters. 14: 2221-6. PMID 15081013 DOI: 10.1016/j.bmcl.2004.02.017 |
0.278 |
|
| 2003 |
Cochran S, Li C, Fairweather JK, Kett WC, Coombe DR, Ferro V. Probing the interactions of phosphosulfomannans with angiogenic growth factors by surface plasmon resonance. Journal of Medicinal Chemistry. 46: 4601-8. PMID 14521421 DOI: 10.1021/jm030180y |
0.236 |
|
| 2002 |
Yu G, Gunay NS, Linhardt RJ, Toida T, Fareed J, Hoppensteadt DA, Shadid H, Ferro V, Li C, Fewings K, Palermo MC, Podger D. Preparation and anticoagulant activity of the phosphosulfomannan PI-88. European Journal of Medicinal Chemistry. 37: 783-91. PMID 12446036 DOI: 10.1016/S0223-5234(02)01347-8 |
0.326 |
|
| 2002 |
Ferro V, Li C, Fewings K, Palermo MC, Linhardt RJ, Toida T. Determination of the composition of the oligosaccharide phosphate fraction of Pichia (Hansenula) holstii NRRL Y-2448 phosphomannan by capillary electrophoresis and HPLC. Carbohydrate Research. 337: 139-46. PMID 11814445 DOI: 10.1016/S0008-6215(01)00300-7 |
0.29 |
|
| Show low-probability matches. |